Source link : https://newshealth.biz/health-news/novel-glp-1-pill-for-obesity-passes-phase-iii-test/
(MedPage Today) — An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial. At week 72, orforglipron at multiple doses proved superior to placebo… Source link : https://www.medpagetoday.com/meetingcoverage/easd/117495 Author : Publish date : 2025-09-16 22:01:00 Copyright for syndicated content belongs to the linked Source.
The post Novel GLP-1 Pill for Obesity Passes Phase III Test first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-16 22:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8